Ad is loading...
AGEN
Price
$3.58
Change
+$0.44 (+14.01%)
Updated
Dec 6 closing price
NCNA
Price
$1.33
Change
+$0.11 (+9.02%)
Updated
Dec 6, 04:59 PM (EDT)
Ad is loading...

AGEN vs NCNA

Header iconAGEN vs NCNA Comparison
Open Charts AGEN vs NCNABanner chart's image
Agenus
Price$3.58
Change+$0.44 (+14.01%)
Volume$441.27K
CapitalizationN/A
NuCana
Price$1.33
Change+$0.11 (+9.02%)
Volume$496
CapitalizationN/A
AGEN vs NCNA Comparison Chart
Loading...
AGEN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NCNA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
AGEN vs. NCNA commentary
Dec 09, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGEN is a Buy and NCNA is a Buy.

COMPARISON
Comparison
Dec 09, 2024
Stock price -- (AGEN: $3.58 vs. NCNA: $1.34)
Brand notoriety: AGEN and NCNA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGEN: 87% vs. NCNA: 82%
Market capitalization -- AGEN: $74.14M vs. NCNA: $4.87M
AGEN [@Biotechnology] is valued at $74.14M. NCNA’s [@Biotechnology] market capitalization is $4.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $489.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.71B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGEN’s FA Score shows that 0 FA rating(s) are green whileNCNA’s FA Score has 1 green FA rating(s).

  • AGEN’s FA Score: 0 green, 5 red.
  • NCNA’s FA Score: 1 green, 4 red.
According to our system of comparison, NCNA is a better buy in the long-term than AGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGEN’s TA Score shows that 6 TA indicator(s) are bullish while NCNA’s TA Score has 5 bullish TA indicator(s).

  • AGEN’s TA Score: 6 bullish, 2 bearish.
  • NCNA’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, AGEN is a better buy in the short-term than NCNA.

Price Growth

AGEN (@Biotechnology) experienced а +4.68% price change this week, while NCNA (@Biotechnology) price change was +3.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.01%. For the same industry, the average monthly price growth was -2.68%, and the average quarterly price growth was +10.76%.

Reported Earning Dates

AGEN is expected to report earnings on Aug 08, 2024.

NCNA is expected to report earnings on Aug 14, 2024.

Industries' Descriptions

@Biotechnology (-1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AGEN($74.1M) has a higher market cap than NCNA($4.87M). AGEN (-78.379) and NCNA (-81.880) have similar YTD gains . NCNA has higher annual earnings (EBITDA): -33.04M vs. AGEN (-77.64M). AGEN has more cash in the bank: 44.8M vs. NCNA (11.6M). NCNA has less debt than AGEN: NCNA (281K) vs AGEN (78.4M). AGEN has higher revenues than NCNA: AGEN (160M) vs NCNA (0).
AGENNCNAAGEN / NCNA
Capitalization74.1M4.87M1,522%
EBITDA-77.64M-33.04M235%
Gain YTD-78.379-81.88096%
P/E Ratio0.46N/A-
Revenue160M0-
Total Cash44.8M11.6M386%
Total Debt78.4M281K27,900%
FUNDAMENTALS RATINGS
AGEN vs NCNA: Fundamental Ratings
AGEN
NCNA
OUTLOOK RATING
1..100
714
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
16
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
9394
P/E GROWTH RATING
1..100
96100
SEASONALITY SCORE
1..100
n/a46

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NCNA's Valuation (16) in the Biotechnology industry is significantly better than the same rating for AGEN (97). This means that NCNA’s stock grew significantly faster than AGEN’s over the last 12 months.

NCNA's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as AGEN (100). This means that NCNA’s stock grew similarly to AGEN’s over the last 12 months.

NCNA's SMR Rating (99) in the Biotechnology industry is in the same range as AGEN (100). This means that NCNA’s stock grew similarly to AGEN’s over the last 12 months.

AGEN's Price Growth Rating (93) in the Biotechnology industry is in the same range as NCNA (94). This means that AGEN’s stock grew similarly to NCNA’s over the last 12 months.

AGEN's P/E Growth Rating (96) in the Biotechnology industry is in the same range as NCNA (100). This means that AGEN’s stock grew similarly to NCNA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AGENNCNA
RSI
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
79%
MACD
ODDS (%)
Bullish Trend 3 days ago
71%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 14 days ago
84%
Bullish Trend 13 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
81%
Aroon
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
89%
View a ticker or compare two or three
Ad is loading...
AGEN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NCNA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
S25.780.89
+3.58%
SentinelOne
PED0.810.01
+1.25%
PEDEVCO Corp
ADTN8.430.03
+0.36%
ADTRAN Holdings
VZ42.37-0.18
-0.42%
Verizon Communications
CODI23.18-0.25
-1.07%
Compass Diversified

NCNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NCNA has been closely correlated with RNAC. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if NCNA jumps, then RNAC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NCNA
1D Price
Change %
NCNA100%
+9.84%
RNAC - NCNA
93%
Closely correlated
+9.26%
AGEN - NCNA
93%
Closely correlated
+14.01%
SNPX - NCNA
92%
Closely correlated
-4.05%
ALLR - NCNA
86%
Closely correlated
+1.85%
NRXP - NCNA
85%
Closely correlated
+2.52%
More